TAG:
american association of clinical chemistry
All-Star Vitamin D Panel Looks at Lab Challenges
By Robert Michel | From the Volume XVI No. 10 – July 20, 2009 Issue
CEO SUMMARY: Need proof that the issues surrounding today’s Vitamin 25(OH) D are of keen interest to laboratory professionals? Not only did the EXECUTIVE WAR COLLEGE’S in depth sessions on Vitamin D draw a large audience and enthusiastic participation by attendees, but within…
Using a 1997 Bid Model In a 2007 Health Market
By Robert Michel | From the Volume XIV No. 18 – December 31, 2007 Issue
CEO SUMMARY: It’s been a long path from concept to implementation for a competitive bidding demonstration involving clinical lab services. It was in the mid-1980s when CMS commenced work on designing such a demonstration. In the 1990s, RTI International continued devel…
New Book Offers Guidance About Management of POCT
By Robert Michel | From the Volume XIII No. 14 – October 16, 2006 Issue
WHENEVER A TREND COMES OF AGE, books appear to offer guidance on how to best benefit from such a trend. In the laboratory profession, point-of-care testing (POCT) is an example of a trend which is now ubiquitous in most large healthcare organizations. Another trend currently gathering momentum in bo…
Siemens’ IVD Purchases Are a Major Investment
By Robert Michel | From the Volume XIII No. 11 – August 14, 2006 Issue
CEO SUMMARY: In the space of just nine weeks, Siemens AG purchased Diagnostic Products Corp. (DPC) and Bayer Diagnostics. Siemens paid $1.86 billion and $5.31 billion, respectively, for the two invitro diagnostics (IVD) companies. Once it closes the acquisition of Bayer Diagnostics, Sieme…
“State of Industry” Report On Molecular Diagnostics
By Robert Michel | From the Volume X No. 10 – July 28, 2003 Issue
CEO SUMMARY: Enterprise Analysis Corporation has launched an ambitious survey that will include 150 laboratories performing molecular testing in the United States. Last week it released information about the first 51 labs contacted in this effort. The survey provides an intriguing look at…
AACC and CAP Meetings Generate Useful Insights
By Robert Michel | From the Volume X No. 10 – July 28, 2003 Issue
IT WAS A BUSY TIME LAST WEEK on the lab industry meeting circuit. THE DARK REPORT made the rounds and uncovered some valuable intelligence for lab directors and pathologists. First on the meeting tour was Philadelphia, site of the American Association of Clinical Chemistry (AACC) a…
“November 18, 2002 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
Antitrust regulators are signaling displeasure about a growing number of business activities in healthcare. Timothy Muris, Chairman of the Federal Trade Commission (FTC), was in Chicago on November 7 to address a group of lawyers and business people. He told them that the FTC “cont…
CPI Lab Fee Adjustment Threatened by New Bill
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
CEO SUMMARY: Once again, the laboratory testing industry has been singled out as a healthcare “whipping boy” by Congressional aides. In working to develop the next federal budget, legislators again propose to deny annual CPI price updates for laboratory tests. This won’t be anything…
Washington G-2, AACC, Cerner, IBM, Visible Genetics, Bio-Reference Labs
By Robert Michel | From the Volume VIII No. 14 – October 15, 2001 Issue
LAB MEETINGS CONTINUE WITH STRONG ATTENDANCE DESPITE THE HASSLES that now come with cross-country travel, laboratorians throughout the United States continue to support industry meetings. Traditionally the largest lab meeting of the fall season, “Lab Institute 2001” expects good attenda…
Institute of Medicine Calls For 12 Medicare Lab Reforms
By Robert Michel | From the Volume VIII No. 6 – April 30, 2001 Issue
CEO SUMMARY: Since 1987, the clinical lab industry has endured almost non-stop cuts in the absolute level of Medicare reimbursement for lab testing. But the time may be ripe for laboratories to work together to effect far-reaching reforms to Medicare laboratory payment policies. Just as t…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized